Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-14-011208
Filing Date
2014-07-02
Accepted
2014-07-02 11:03:41
Documents
2
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3181
2 ex24heffernan.txt EX-24 3936
  Complete submission text file 0001179110-14-011208.txt   8770
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
ADVANCED CELL TECHNOLOGY, INC. (Issuer) CIK: 0001140098 (see all company filings)

EIN.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Business Address
Heffernan Michael Thomas (Reporting) CIK: 0001448914 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50295 | Film No.: 14954894